Repatha (evolocumab) - Amgen, Astellas
Preventing the First Event ... and the Last? Lessons From VESALIUS-CV. (PubMed, Circulation) - Sep 1, 2026 - No abstract available 
Journal • Atherosclerosis • Cardiovascular • Coronary Artery Disease
http://www.ncbi.nlm.nih.gov/pubmed/42670292
 
Fatima Rodriguez; Michael D Shapiro
 
Sep 1, 2026
 
Prev Next